학술논문

Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40
Document Type
Article
Source
In Ophthalmology August 2024 131(8):967-974
Subject
Language
ISSN
0161-6420